QT Imaging Appoints Seasoned Accounting Executive as Chief Financial Officer
QTIHNOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (OTCQB: QTIH), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the appointment of Jay Jennings as its new Chief Financial Officer, with overall responsibility for operational finance, financial reporting, budgeting and strategic planning, and treasury management. Upon his appointment becoming effective on September
QT Imaging Receives $5.0 Million in New Funding from Lynrock Lake to Repurchase and Cancel All Yorkville Warrants
QTIHNOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (OTCQB: QTIH), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce that it has received $5.0 million in additional financing via a restated and amended senior secured term loan with Lynrock Lake Master Fund LP (“Lynrock Lake”). QT Imaging has used the net proceeds from the transaction to repurchase in full the warrants
QT Imaging Inks Exclusive Distribution Agreement with Gulf Medical for Saudi Arabia
QTIHNOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QTI” or the “Company”) (OTCQB: QTIH), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce that it has entered into an exclusive distribution agreement (the "Agreement") with Gulf Medical Co. (“GMC”) in Saudi Arabia (the "Territory"). The U.S. FDA-cleared QTI Breast Acoustic CT™ scanner is the first non-invasive breast imaging technology that provid
QT Imaging Holdings Announces Results of First Annual Stockholder Meeting
QTIHNOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (OTCQB: QTIH), a medical device company engaged in the research, development, and commercialization of innovative body imaging systems, announced today that at the Annual Meeting of Company’s stockholders (the “Annual Meeting”) held on August 19, 2025, the Company’s stockholders voted to approve (i) the election of Daniel Dickson and James Greene as Class I directors to serve until the Company’s 2028 Annu
QT Imaging Announces Continuous Strong Revenue Growth and Enhanced Balance Sheet in the Second Quarter 2025
QTIHNOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (OTCQB: QTIH) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the three and six months ended June 30, 2025, and provided a business update. “We are pleased to report that the strong business momentum from the first quarter carried through Q2, and in many ways, we are even more energized by the signi
Ladenburg Thalmann Initiates Coverage On QT Imaging Holdings with Buy Rating, Announces Price Target of $3.4
QTIH